GSK Again Pays Premium to Acquire China-Originated Asset via Overseas Biotech Amid Booming Cross-Border Financing

Haoyue Values

MissionEmpower with Capital, Build an Excellent Healthcare Enterprise

VisionTo become the most outstanding investment bank in China's healthcare industry

HaoYue Capital, founded in January 2014, is a leading investment bank in China that focuses on the healthcare industry. Headquartered in Shanghai, the company has regional offices in Beijing, Shenzhen, Hong Kong, and Singapore. HaoYue Capital is committed to leveraging capital and research-driven insights to help outstanding enterprises in China's healthcare sector successfully access the capital markets and create added value for clients. The firm closely tracks market dynamics and investment trends in healthcare, with research and transaction expertise spanning innovative pharmaceuticals, cutting-edge medical devices, IVD and life sciences, health services, and digital healthcare. As of 2024, HaoYue Capital has completed hundreds of projects. Over the past decade, it has maintained a dominant position across various healthcare sub-sectors through its deep expertise in private equity financing, mergers and acquisitions, and complex transactions involving publicly listed companies.